Findings
========

Background
----------

Open globe injuries (OGI) are a common cause of infectious endophthalmitis. The incidence of endophthalmitis in this setting varies from 3% to 48% in various studies, depending on a variety of factors which include setting of trauma, delay of repair, retained intraocular foreign body, and involvement of the crystalline lens \[[@B1]\]. Post-traumatic endophthalmitis is either a community-acquired infection from the unsterile material causing trauma or caused by the inoculation of the normal ocular flora at the time of injury. The purpose of the study is to describe the microbial spectrum and antimicrobial susceptibility in cases of endophthalmitis after OGI and to compare the results with the earlier published data from the same center \[[@B2]\].

Methods
-------

This was a retrospective, non-comparative, consecutive case series. Microbiology records were reviewed of all the culture-proven endophthalmitis cases after OGI treated at L. V. Prasad Eye Institute, Hyderabad, India, between January 2006 and March 2013. Bacterial isolates were identified using Analytical Profile Index (API, Bio Meriux, France). The isolate susceptibility to various antimicrobials was determined by the Kirby-Bauer disk diffusion method. Susceptibilities for fungal isolates were not performed. The study was approved by the Institutional Review Board of L. V. Prasad Eye Institute and adhered to the guidelines of the Declaration of Helsinki.

Results
-------

A total of 620 isolates from 581 samples were identified. A total of 38 samples (6.5%) had polymicrobial infection; 37 samples grew two isolates, and one sample grew three organisms. The isolates included gram-positive cocci (296, 47.7%), gram-positive bacilli (117, 18.8%), gram-negative bacteria (142, 22.9%), fungi (55, 8.87%), and *Corynebacterium* (10, 1.61%) (Table [1](#T1){ref-type="table"}).

###### 

Microbiological spectrum and antimicrobial susceptibilities in patients with endophthalmitis following open globe injuries

  **Organism**                           **Total/percentage(previous study)**^**2**^   **Total/percentage (current study)**    **Amikacin**  **Cefazolin**   **Ceftazidime**   **Chloramphenicol**   **Gentamicin**   **Gatifloxacin**   **Ciprofloxacin**   **Moxifloxacin**   **Vancomycin**   **Ofloxacin**                                                                                                                           
  -------------------------------------- --------------------------------------------- -------------------------------------- -------------- --------------- ----------------- --------------------- ---------------- ------------------ ------------------- ------------------ ---------------- --------------- ----- ------ ----- ----- ------ ----- ----- ------ ----- ----- ------ ----- ----- ------ ----- ----- ------ ----- ----- ------
  Gram-positive cocci                    63/45.3                                       296/47.7                                    274       155             56.5              294                   266              90.4               137                 79                 57.6             295             284   96.2   295   217   73.5   292   263   90.1   296   219   73.9   239   206   86.2   289   284   98.2   295   240   81.4
   Coagulase-negative *Staphylococcus*   25/18                                         97/15.6                                      86       81              94.2              96                    90               93.7               41                  18                 43.9             96              93    96.9   97    89    91.7   97    96    98.9   97    75    77.3   75    69    92     95    93    97.9   97    76    78.4
   *Staphylococcus aureus*               5/3.6                                         11/1.8                                       11       11              100               11                    11               100                5                   3                  60               11              11    100    11    10    90.9   11    10    90.9   11    5     45.4   10    8     80     11    11    100    11    6     54.5
   *Streptococcus* sp.                   30/21.6                                       172/27.7                                    163       52              31.9              172                   154              89.5               81                  54                 66.6             172             166   96.5   172   108   62.7   169   143   84.6   172   127   73.8   143   119   83.2   168   165   98.2   171   143   83.6
   Other gram-positive cocci             3/2.2                                         16/2.6                                       14       11              78.6              15                    11               73.3               10                  4                  40.0             16              14    87.5   15    10    66.7   15    14    93.3   16    12    75.0   11    10    90.9   15    15    100    16    15    93.7
  Gram-positive bacilli                  24/17.3                                       117/18.8                                    114       109             95.6              115                   63               54.7               75                  12                 16               117             109   93.1   117   112   95.7   117   116   99.1   116   108   93.1   101   99    98.0   114   109   95.6   117   116   99.1
   *Bacillus* sp.                        20/14.4                                       106/17.1                                    103       101             98.1              104                   54               51.9               67                  8                  11.9             106             98    92.4   106   105   99.1   106   105   99.0   106   101   95.2   94    92    97.9   103   98    95.1   106   106   100
   Other GPB                             4/2.9                                         11/1.8                                       11       8               72.7              11                    9                81.8               8                   4                  50               11              11    100    11    7     63.6   11    11    100    10    7     70     7     7     100    11    11    100    11    10    90.9
  Gram negative organism                 25/18                                         142/25                                      140       117             83.5              16                    7                43.7               136                 105                77.2             141             125   88.6   142   125   88.0   141   131   92.9   142   123   86.6   116   96    82.7   16    4     25     142   127   89.4
   *Pseudomonas* sp.                     10/7.2                                        16/2.6                                       16       12              75                1                     0                0                  16                  11                 68.7             16              5     31.2   16    12    75     16    12    75.0   16    11    68.7   13    8     61.5   1     0     0      16    11    68.7
   *Enterobacter sp*.                    2/1.4                                         25/4.0                                       25       22              88                5                     2                40                 23                  21                 91.3             25              24    96     24    23    95.8   25    24    96     25    24    96     19    19    100    5     2     40     25    24    96
   *E. coli*                             4/2.9                                         14/2.3                                       14       12              85.7              \-                    \-               \-                 14                  12                 85.7             14              13    92.8   14    13    92.8   14    11    78.6   14    11    78.6   12    7     58.3   \-    \-    \-     14    10    71.4
   *Haemophilus sp*.                     \-                                            14/2.3                                       14       7               50                \-                    \-               \-                 13                  5                  38.5             14              14    100    14    11    78.6   14    14    100    14    12    85.7   13    11    84.6   \-    \-    \-     14    14    100
   Other gram-negative organisms         9/6.5                                         73/11.8                                      71       64              90.1              10                    5                50                 70                  56                 80               72              69    95.8   74    66    89.2   72    70    97.2   73    65    89     59    51    86.4   10    2     20     73    68    93.2
  *Corynebacterium*                      5/3.6                                         10/1.6                                       5        4               80                10                    9                90                 3                   0                  0                10              9     90     10    9     90     10    9     90.0   10    7     70     8     6     75.0   10    10    100    10    9     90
   Total bacteria                        119/85.6                                      565/91.1                                    533       385             72.2              435                   345              79.3               351                 196                55.8             563             527   93.6   564   463   82.0   560   519   92.7   564   457   81.1   464   407   87.7   429   407   94.8   564   492   87.2
   Total fungi                           20/14.4                                       55/8.9                                    Not done                                                                                                                                                                                                                                                                                                
    *Aspergillus*                        9/6.5                                         20/3.2                                                                                                                                                                                                                                                                                                                                            
    *Acremonium*                         1/0.7                                         1/0.32                                                                                                                                                                                                                                                                                                                                            
    *Bipolaris*                          1/0.7                                         2/0.32                                                                                                                                                                                                                                                                                                                                            
    *Cladosporium*                       1/0.7                                         2/0.32                                                                                                                                                                                                                                                                                                                                            
    *Candida*                            \-                                            3/0.48                                                                                                                                                                                                                                                                                                                                            
    *Fusarium*                           2/1.4                                         1/0.16                                                                                                                                                                                                                                                                                                                                            

All isolates were not tested for susceptibility to all antibiotics leading to '*n*' being less than the total isolates. GPB, gram-positive bacilli; *n*, number of isolates tested for antibiotic susceptibility; *S*, number of isolates sensitive to the antibiotic.

The most common organism isolated was *Bacillus* spp. (106/620, 17.1%) followed by *Streptococcus pneumoniae* (105/620, 16.9%) and coagulase-negative *Staphylococci* (97/620, 15.6%). *Enterobacter* was the most common gram-negative isolate (25 of 142 gram-negative isolates). *Aspergillus* spp. was the most common fungus (20 of 55 fungal isolates) (Table [1](#T1){ref-type="table"}).

The spectrum of the isolates identified in this series was similar to that reported in 1999 from the same center \[[@B2]\], with coagulase-negative *Staphylococci* (CoNS), *Streptococcus*, and *Bacilllus* sp. being the three most common organisms (Table [1](#T1){ref-type="table"}). The only differences in the spectrum of organisms were the relatively lower incidence of fungal endophthalmitis in the current study (current 8.9% vs earlier 14.4%) and higher incidence of gram-negative isolates (current 25% vs earlier 18%). But, both of these were not statistically significant (*p* = 0.257 and 0.058, respectively).

Both gram-positive cocci and gram-positive bacilli were generally susceptible to vancomycin (98.2% and 95.6%, respectively). *Bacillus* sp. was also susceptible to vancomycin (95.1%) as well as to gentamicin (99.1%), amikacin (98.1%), chloramphenicol (92.4%), ciprofloxacin (95.2%), ofloxacin (100%), gatifloxacin (99.1%), and moxifloxacin (97.9%) but its susceptibility to ceftazidime was very poor (11.9%). Gram-negative bacteria were generally susceptible to gatifloxacin (92.9%) followed by ofloxacin (89.4%), chloramphenicol (88.6%), ciprofloxacin (86.6%), amikacin (83.5%), and ceftazidime (77.2%). Among the fluoroquinolones, both gram-positive and gram-negative organisms were most susceptible to gatifloxacin (92.7% and 92.9%, respectively). The antimicrobial susceptibilities of the various isolates are detailed in the Table [1](#T1){ref-type="table"}.

Discussion
----------

The susceptibility of gram-positive organisms continues to be highest to vancomycin. Susceptibility of CoNS to ciprofloxacin had reduced from 100% in 1999 report \[[@B2]\] to 77.3% in the current report (*p* = 0.007). Similar fluoroquinolone susceptibility trend towards CoNS was noted in the report by Schimel et al. \[[@B3]\]. Susceptibility of gram-negative organisms has slightly decreased over the last two decades. In the 1999 report, gram-negative organisms were 100% susceptible to ciprofloxacin and 95% to amikacin \[[@B2]\]. This has now reduced to 86.6% and 83.5%, respectively, but this change was statistically not significant (*p* = 0.078 and *p* = 0.206, respectively). The susceptibility of gram-negative isolates to ceftazidime has increased from 66.7% in 1999 \[[@B2]\] to 77.2% in the current study, and this difference is also not significant (*p* \> 0.05).

The current study indicates that the microbiological spectrum in post-traumatic endophthalmitis has remained the same over the last two decades. Intravitreal vancomycin remains the drug of choice for empiric coverage of gram-positive bacteria. Susceptibility of gram-negative bacteria to commonly used antimicrobials including amikacin and ciprofloxacin has decreased by 10% to 15% and to ceftazidime has increased by 10.5% as compared to the past two decades though statistically not significant. Thus, intravitreal amikacin can be used for empiric coverage of gram-negative bacteria. Ofloxacin is a good option as a systemic antibiotic for broad-spectrum empiric coverage. Also, we report a high prevalence of *Bacillus* endophthalmitis in open globe injuries that are known to be highly virulent with rapid progression to panophthalmitis \[[@B4]\]. Similar high prevalence of *Bacillus* endophthalmitis following open globe injuries has been reported in the literature \[[@B5],[@B6]\].

Conclusions
-----------

The microbiological spectrum remains similar over the past 14 years. The susceptibility of gram-negative organisms to commonly used antibiotics has decreased over the time period. Empiric treatment of post-traumatic endophthalmitis with broad-spectrum, combination antibiotics based on the susceptibility pattern in that region is very important for successful anatomical and visual outcomes.
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